NCT02497924View on ClinicalTrials.gov

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Anemia, Sickle Cell
Interventions
DRUG

GBT440

GBT440 capsules followed by single dose of \[C14\] GBT440 oral suspension

Trial Locations (1)

53704

Covance Early Clinical Services, Madison

Sponsors
All Listed Sponsors
lead

Global Blood Therapeutics

INDUSTRY

NCT02497924 - A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter